Sessioni Comunicazioni Orali


Antineoplastic Drugs

Wednesday, October 25th / 14.30-16.30
10MICRORNA-574-5P MODULATES MICROSOMAL PROSTAGLANDIN E SYNTHASE EXPRESSION AND PROSTAGLANDIN E2 BIOSYNTHESIS IN A549 HUMAN LUNG CARCINOMA CELLS
Contursi A., Saul MJ., Baumann I., Dovizio M., Tacconelli S., Korotkova M., Jakobsson PJ., Suess B., Steinhilber D., Patrignani P.
11ANTICANCER EFFECTS OF NOVEL LDH-A AND GLUT-1 INHIBITORS ON HUMAN PANCREATIC ADENOCARCINOMA CELLS ASPC-1.
Citi V., Granchi C., Piragine E., Testai L., Breschi MC., Minutolo F., Calderone V., Martelli A.
12DUAL TARGETING OF EPH-EPHRIN SYSTEM AND VEGFR INHIBITS TUMOR GROWTH AND INCREASES SURVIVAL IN GLIOBLASTOMA
Giorgio C., Castelli R., Festuccia C., Vacondio F., Gravina GL., Chiodelli P., Rusnati M., Lodola A., Barocelli E., Tognolini M.
13KEY PATHWAYS AND EMERGING PLAYERS IN HUMAN MELANOMA DEVELOPMENT AND PROGRESSION
Ianaro AI., Panza EP., De cicco PD., Armogida CA., Ercolano GE., Cirino GC.
14GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) REGULATES TUMOR DEVELOPMENT IN A MOUSE MODEL OF CEBPA MUTANT ACUTE MYELOID LEUKEMIA.
Bereshchenko O., Flamini S., Sorcini D., Donnini S., Adamo F., Gagliardi A., Bruscoli S., Riccardi C.
15ANNEXIN A1 CONTRIBUTES TO PANCREATIC CANCER CELL PHENOTYPE, BEHAVIOUR AND METASTATIC POTENTIAL INDEPENDENTLY OF FORMYL PEPTIDE RECEPTOR PATHWAY
Belvedere R., Bizzarro V., Parente L., Petrella A.
16High density lipoproteins inhibit oxidative stress-induced prostate cancer cell proliferation
Ruscica M., Botta M., Ferri N., Giorgio E., Macchi C., Franceschini G., Magni P., Calabresi L., Gomaraschi M.
17NON THERMAL PLASMA AS INNOVATIVE ANTICANCER STRATEGY
Turrini E., Catanzaro E., Calcabrini C., Greco G., Stancampiano A., Simoncelli E., Laurita R., Gherardi M., Colombo V., Hrelia P., Fimognari C.
18Interaction between mPGES-1 and iNOS in the activation of stem-like phenotype in EGFR-driven epithelial tumor cells
Terzuoli E., Giachetti A., Ziche M., Donnini S.